Cadrenal Therapeutics Statistics

Total Valuation

CVKD has a market cap or net worth of $32.63 million. The enterprise value is $22.61 million.

Market Cap	32.63M
Enterprise Value	22.61M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

CVKD has 1.88 million shares outstanding. The number of shares has increased by 35.59% in one year.

Current Share Class	1.88M
Shares Outstanding	1.88M
Shares Change (YoY)	+35.59%
Shares Change (QoQ)	+48.53%
Owned by Insiders (%)	30.69%
Owned by Institutions (%)	7.02%
Float	1.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.16
P/TBV Ratio	4.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.77

Current Ratio	3.77
Quick Ratio	3.75
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -140.78% and return on invested capital (ROIC) is -90.41%.

Return on Equity (ROE)	-140.78%
Return on Assets (ROA)	-73.49%
Return on Invested Capital (ROIC)	-90.41%
Return on Capital Employed (ROCE)	-147.33%
Revenue Per Employee	n/a
Profits Per Employee	-$2.66M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +169.94% in the last 52 weeks. The beta is 1.45, so CVKD's price volatility has been higher than the market average.

Beta (5Y)	1.45
52-Week Price Change	+169.94%
50-Day Moving Average	17.70
200-Day Moving Average	14.00
Relative Strength Index (RSI)	53.99
Average Volume (20 Days)	20,431

Short Selling Information

The latest short interest is 32,088, so 1.71% of the outstanding shares have been sold short.

Short Interest	32,088
Short Previous Month	52,078
Short % of Shares Out	1.71%
Short % of Float	2.46%
Short Ratio (days to cover)	1.26

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.96M
Pretax Income	-6.24M
Net Income	-10.65M
EBITDA	-10.96M
EBIT	-10.96M
Earnings Per Share (EPS)	-$8.73

Full Income Statement

Balance Sheet

The company has $10.02 million in cash and n/a in debt, giving a net cash position of $10.02 million or $5.33 per share.

Cash & Cash Equivalents	10.02M
Total Debt	n/a
Net Cash	10.02M
Net Cash Per Share	$5.33
Equity (Book Value)	7.44M
Book Value Per Share	4.17
Working Capital	7.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.36 million and capital expenditures -$6,537, giving a free cash flow of -$7.36 million.

Operating Cash Flow	-7.36M
Capital Expenditures	-6,537
Free Cash Flow	-7.36M
FCF Per Share	-$3.92

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CVKD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.59%
Shareholder Yield	-35.59%
Earnings Yield	-32.64%
FCF Yield	-22.57%

Analyst Forecast

The average price target for CVKD is $32.00, which is 84.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.00
Price Target Difference	84.33%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-29.54%

Stock Forecasts

Stock Splits

The last stock split was on August 20, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Aug 20, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1